Nebulizer Market Rising in United States and Europe | Future Scope
The global Nebulizer market size is projected to reach USD 1,778.8 million by 2027, exhibiting a CAGR of 8.1% during the forecast period. Increasing prevalence of respiratory disorders around the world will be the prime growth propeller for this market, shares Fortune Business Insights™ in its new report, titled “Nebulizer Market Size, Share & COVID-19 Impact Analysis, By Type (Jet Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer) By Modality (Portable, and Table-top) By End User (Hospitals, Clinics, and Homecare Settings), and Regional Forecast, 2020-2027”.
The World Health Organization (WHO) states that respiratory
diseases are the foremost cause of death and disability worldwide. According to
its estimates, chronic obstructive pulmonary disorder (COPD) afflicts around 65
million and kills 3 million people every year. Similarly, pneumonia also kills
millions of people annually and is the leading cause of mortality among
children under 5 years of age. Furthermore, WHO data indicates that lung cancer
is the deadliest cancer, killing 1.6 million people every year. Nebulizer play
a key role in managing these chronic and potentially fatal lung disorders and
as the incidence of these disorders grows, the demand for Nebulizer will
continue to surge.
Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/nebulizers-market-100707
OMRON Healthcare and AAFA Collaborate to Offer
Better Respiratory Medical Care to Underserved Societies
OMRON Healthcare, Inc., who is a global trendsetter in respiratory
health technologies with over 40 years of headship in the medical
device classification, is working co-jointly with the Asthma and Allergy
Foundation of America (AAFA), which is the foremost patient organization for
people dealing with asthma and allergies to lift admission to
prescription-grade respiratory technologies. Moreover, OMRON’s backing is also
likely to aid AAFA in supplying educational material to communities in most
need of such resources.
OMRON is donating a variety of its medical-grade nebulizers, which
AAFA will apply for crucial advocacy and education initiatives that assist the
most susceptible people in the asthma community.
Rising Demand for Home Healthcare Devices to Surge
Demand for Nebulizers
The increasing prices of healthcare services and hospital stays
have resulted in an inclination of the patient towards getting home treatment,
thereby surging the implementation of breathable medical devices for home
healthcare. Furthermore, the rising demand for effectual inhaled drug delivery
devices and the campaigning of respiratory care devices for home use by several
healthcare organizations are probable to drive the Nebulizer market growth
during the forecast period.
The report
states that the market value was at USD 909.7 million in 2019. Its other
highlights include:
·
Valuable insights into the key market
drivers, trends, and restraints;
·
Exhaustive analysis of the upcoming
market opportunities;
·
In-depth examination of the impact of
the COVID-19 outbreak on the market; and
·
Comprehensive study of the regional
prospects and competitive dynamics influencing the market.
Related
Topics :
Kidney
Stone Management Market
Pain
Management Devices Market
Market
Opportunity
Rapid
Transmission of the COVID-19 Infection to Create Immediate Growth Opportunities
The SARS-CoV-2 infection attacks the respiratory tract and lungs,
causing shortness of breath, acute breathing problems, and pneumonia, along
with a persistent fever and cough. People with preexisting lung disorders such
as asthma are at high risk of contracting the COVID-19 infection. According to
the Centers for Disease Control and Prevention (CDC), asthma patients are
highly recommended to carry inhalers or portable Nebulizer with them as these
devices can efficiently open the lungs and allow them to function normally. In
this scenario, the uptake of inhalable drug delivery devices is likely to spike
and favor the Nebulizer market growth. The only worry with these devices, as
pointed out by the Asthma and Allergy Foundation of America, is their potential
to transmit the infection among patients as well as healthcare workers,
especially in healthcare facilities. If this issue is addressed, players can
capitalize on the current pandemic and expand their presence in the market.
Speak To
Our Analyst:
About Us:
Fortune Business Insights™ delivers accurate data and innovative
corporate analysis, helping organizations of all sizes make appropriate
decisions. We tailor novel solutions for our clients, assisting them to address
various challenges distinct to their businesses. Our aim is to empower them
with holistic market intelligence, providing a granular overview of the market
they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Comments
Post a Comment